Literature DB >> 9169414

Characterization of Lnk. An adaptor protein expressed in lymphocytes.

S Takaki1, J D Watts, K A Forbush, N T Nguyen, J Hayashi, J Alberola-Ila, R Aebersold, R M Perlmutter.   

Abstract

Stimulation of the T cell antigen receptor (TCR) activates a set of non-receptor protein tyrosine kinases that assist in delivering signals to the cell interior. Among the presumed substrates for these kinases, adaptor proteins, which juxtapose effector enzyme systems with the antigen receptor complex, figure prominently. Previous studies suggested that Lnk, a 38-kDa protein consisting of a single SH2 domain and a region containing potential tyrosine phosphorylation sites, might serve to join Grb2, phospholipase C-gamma1, and phosphatidylinositol 3-kinase to the TCR. To elucidate the physiological roles of Lnk in T cell signal transduction, we isolated the mouse Lnk cDNA, characterized the structure of the mouse Lnk gene, and generated transgenic mice that overproduce Lnk in thymocytes. Here we report that although Lnk becomes phosphorylated during T cell activation, it plays no limiting role in the TCR signaling process. Moreover, we have distinguished p38(Lnk) from the more prominent 36-kDa tyrosine phosphoproteins that appear in activated T cells. Together these studies suggest that Lnk participates in signaling from receptors other than antigen receptors in lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169414     DOI: 10.1074/jbc.272.23.14562

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Clinical impact of circulating CD34-positive cells on bone regeneration and healing.

Authors:  Ryosuke Kuroda; Tomoyuki Matsumoto; Yohei Kawakami; Tomoaki Fukui; Yutaka Mifune; Masahiro Kurosaka
Journal:  Tissue Eng Part B Rev       Date:  2014-02-10       Impact factor: 6.389

2.  Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis.

Authors:  Lilian Varricchio; Annalisa Mancini; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2009-06-01       Impact factor: 2.929

3.  LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.

Authors:  Julie Devallière; Mathias Chatelais; Juliette Fitau; Nathalie Gérard; Philippe Hulin; Laura Velazquez; Christopher E Turner; Béatrice Charreau
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

4.  Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.

Authors:  David J Olivos; Marta Alvarez; Ying-Hua Cheng; Richard Adam Hooker; Wendy A Ciovacco; Monique Bethel; Haley McGough; Christopher Yim; Brahmananda R Chitteti; Pierre P Eleniste; Mark C Horowitz; Edward F Srour; Angela Bruzzaniti; Robyn K Fuchs; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2017-04-18       Impact factor: 4.429

Review 5.  The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.

Authors:  N Maslah; B Cassinat; E Verger; J-J Kiladjian; L Velazquez
Journal:  Leukemia       Date:  2017-05-09       Impact factor: 11.528

6.  Genetic loss of SH2B3 in acute lymphoblastic leukemia.

Authors:  Arianne Perez-Garcia; Alberto Ambesi-Impiombato; Michael Hadler; Isaura Rigo; Charles A LeDuc; Kara Kelly; Chaim Jalas; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Martin S Tallman; Maddalena Paganin; Giuseppe Basso; Wei Tong; Wendy K Chung; Adolfo A Ferrando
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

7.  Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins.

Authors:  S Takaki; K Sauer; B M Iritani; S Chien; Y Ebihara; K Tsuji; K Takatsu; R M Perlmutter
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

8.  Lnk-dependent axis of SCF-cKit signal for osteogenesis in bone fracture healing.

Authors:  Tomoyuki Matsumoto; Masaaki Ii; Hiromi Nishimura; Taro Shoji; Yutaka Mifune; Atsuhiko Kawamoto; Ryosuke Kuroda; Tomoaki Fukui; Yohei Kawakami; Tomoya Kuroda; Sang Mo Kwon; Hiroto Iwasaki; Miki Horii; Ayumi Yokoyama; Akira Oyamada; Sang Yang Lee; Shinya Hayashi; Masahiro Kurosaka; Satoshi Takaki; Takayuki Asahara
Journal:  J Exp Med       Date:  2010-09-20       Impact factor: 14.307

9.  Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction.

Authors:  Jun Seita; Hideo Ema; Jun Ooehara; Satoshi Yamazaki; Yuko Tadokoro; Akiko Yamasaki; Koji Eto; Satoshi Takaki; Kiyoshi Takatsu; Hiromitsu Nakauchi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

10.  SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.

Authors:  Maya Koren-Michowitz; Sigal Gery; Takayuki Tabayashi; Dechen Lin; Rocio Alvarez; Arnon Nagler; H Phillip Koeffler
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.